Bryce Istvan
Long/short equity, growth, biotech, CFA
Bryce Istvan
Contributor since: 2011
Company: Oncoceutics
Ketan Desai, Contributor
Zach Hartman, PhD, Contributor
Amvona, Contributor
Ben Yoffe, Contributor
Sharon di Stefano, Contributor
Cory Renauer, Contributor
Craig Keolanui, Contributor
Alexander Maxwell, Contributor
Ryan Brennan, Contributor
Vash Patel, Contributor
Grant Zeng, CFA, Contributor
EnhydrisPECorp, Contributor
Sean Anderson, Contributor
BioNap, Contributor
LifeSci Advisors, Contributor
qia, Contributor
Steven Breazzano, Contributor
Mina Shaker, Contributor
Deborah Gouge, Contributor
Mike Havrilla, Contributor
Matt Tucker, CFA, Contributor
Galileo Russell, Contributor
The Burrill Report, Contributor
Michael Becker, Contributor
J Mintzmyer, Contributor
Brett Korsgaard, Contributor
Jon Crowley, Contributor
John H. Ford, Contributor
Brian Marckx, CFA, Contributor